Добірка наукової літератури з теми "Peptidomimetic inhibitors"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Peptidomimetic inhibitors".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Peptidomimetic inhibitors"
Kikelj, Danijel. "Peptidomimetic Thrombin Inhibitors." Pathophysiology of Haemostasis and Thrombosis 33, no. 5-6 (2003): 487–91. http://dx.doi.org/10.1159/000083850.
Повний текст джерелаDong, Guangping, Iredia D. Iyamu, Jonah Z. Vilseck, Dongxing Chen, and Rong Huang. "Improved Cell-Potent and Selective Peptidomimetic Inhibitors of Protein N-Terminal Methyltransferase 1." Molecules 27, no. 4 (February 18, 2022): 1381. http://dx.doi.org/10.3390/molecules27041381.
Повний текст джерелаTurkson, James, Joon S. Kim, Shumin Zhang, Jing Yuan, Mei Huang, Matthew Glenn, Eric Haura, Said Sebti, Andrew D. Hamilton, and Richard Jove. "Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity." Molecular Cancer Therapeutics 3, no. 3 (March 1, 2004): 261–69. http://dx.doi.org/10.1158/1535-7163.261.3.3.
Повний текст джерелаRandolph, John, and David DeGoey. "Peptidomimetic Inhibitors of HIV Protease." Current Topics in Medicinal Chemistry 4, no. 10 (June 1, 2004): 1079–95. http://dx.doi.org/10.2174/1568026043388330.
Повний текст джерелаCameron Black, W. "Peptidomimetic Inhibitors of Cathepsin K." Current Topics in Medicinal Chemistry 10, no. 7 (May 1, 2010): 745–51. http://dx.doi.org/10.2174/156802610791113450.
Повний текст джерелаMarsters, James C., Robert S. McDowell, Mark E. Reynolds, David A. Oare, Todd C. Somers, Mark S. Stanley, Thomas E. Rawson, et al. "Benzodiazepine peptidomimetic inhibitors of farnesyltransferase." Bioorganic & Medicinal Chemistry 2, no. 9 (September 1994): 949–57. http://dx.doi.org/10.1016/s0968-0896(00)82044-1.
Повний текст джерелаMarsters, James C., Robert S. McDowelll, Mark E. Reynolds, Todd C. Somers, Joseph L. Goldstein, Michael S. Brown, and Guy L. James. "Peptidomimetic inhibitors of Ras farnesylation." Chemistry & Biology 1 (April 1994): viii—ix. http://dx.doi.org/10.1016/1074-5521(94)90021-3.
Повний текст джерелаSantos, André L. S., Filipe P. Matteoli, Leandro S. Sangenito, Marta H. Branquinha, Bruno A. Cotrim, and Gabriel O. Resende. "Asymmetric peptidomimetics containing L-tartaric acid core inhibit the aspartyl peptidase activity and growth of Leishmania amazonensis promastigotes." Acta Parasitologica 63, no. 1 (March 26, 2018): 114–24. http://dx.doi.org/10.1515/ap-2018-0013.
Повний текст джерелаBarbotte, Laetitia, Abdelhakim Ahmed-Belkacem, Stéphane Chevaliez, Alexandre Soulier, Christophe Hézode, Henri Wajcman, Doug J. Bartels, et al. "Characterization of V36C, a Novel Amino Acid Substitution Conferring Hepatitis C Virus (HCV) Resistance to Telaprevir, a Potent Peptidomimetic Inhibitor of HCV Protease." Antimicrobial Agents and Chemotherapy 54, no. 6 (April 5, 2010): 2681–83. http://dx.doi.org/10.1128/aac.01796-09.
Повний текст джерелаKinena, Linda, Gundars Leitis, Iveta Kanepe-Lapsa, Raitis Bobrovs, Kristaps Jaudzems, Vita Ozola, Edgars Suna, and Aigars Jirgensons. "Azole-based non-peptidomimetic plasmepsin inhibitors." Archiv der Pharmazie 351, no. 9 (July 31, 2018): 1800151. http://dx.doi.org/10.1002/ardp.201800151.
Повний текст джерелаДисертації з теми "Peptidomimetic inhibitors"
Appiah, Kubi George. "Development of Peptidomimetic Inhibitors Against Intracellular Targets." The Ohio State University, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=osu1587519549871245.
Повний текст джерелаHirsch, Brett M. "Mechanism-Based Peptidic and Peptidomimetic Human Sirtuin Inhibitors." University of Akron / OhioLINK, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=akron1302055499.
Повний текст джерелаAllwood, Daniel Martin. "Discovery and development of novel non-peptidomimetic inhibitors of XIAP." Thesis, University of Cambridge, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.607657.
Повний текст джерелаVicari, Daniele. "Evaluation Of VEGF Peptide Mimics As Inhibitors Of Angiogenesis." The Ohio State University, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=osu1221509932.
Повний текст джерелаBreuer, Christian [Verfasser]. "Design and Synthesis of Covalent Peptidomimetic Inhibitors for Human Cysteine Cathepsins / Christian Breuer." Bonn : Universitäts- und Landesbibliothek Bonn, 2020. http://d-nb.info/1227990499/34.
Повний текст джерелаWatkins, Andrew M. "An in silico pipeline for the design of peptidomimetic protein-protein interaction inhibitors." Thesis, New York University, 2016. http://pqdtopen.proquest.com/#viewpdf?dispub=10188557.
Повний текст джерелаProtein-protein interactions have historically been branded “undruggable” due to their intrinsic challenges above and beyond protein-small molecule interactions. Incrementally, system after system has been approached by a variety of specialized design strategies. Still, the vast majority of interactions are intractable, and the profusion of individualized strategies leave few general approaches that might be able to extend to recalcitrant systems.
The ecosystem of tools available for developing inhibitors of protein-protein interactions suggests a potential modular strategy for proceeding from protein structure to plausible interaction inhibitors. My dissertation describes an analysis of all the protein-protein interactions containing key interfacial structural motifs found in protein structures catalogued by the Protein Data Bank. This work provides both data on extant protein interactions and specific conclusions regarding directions for further peptidomimetic design. We describe the incorporation of our lab’s peptidomimetic scaffolds into Rosetta and the validation of those methods against valuable biological systems. Finally, I chronicle substantial extension to Rosetta’s capacity to accurately model and design peptidomimetic structures.
Nurbo, Johanna. "Peptidomimetic Enzyme Inhibitors Targeting M. tuberculosis Ribonucleotide Reductase and Hepatitis C Virus NS3 Protease /." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-112345.
Повний текст джерелаKnuhtsen, Astrid. "Searching for inhibitors of the protein arginine methyl transferases : synthesis and characterisation of peptidomimetic ligands." Thesis, University of British Columbia, 2016. http://hdl.handle.net/2429/57228.
Повний текст джерелаPharmaceutical Sciences, Faculty of
Graduate
Kamath, Jayesh Ramrao. "Development of pseudosubstrate-based peptide and peptidomimetic inhibitors of p60ᶜ⁻ˢʳᶜ protein tyrosine kinase using combinatorial chemistry technology". Diss., The University of Arizona, 2000. http://hdl.handle.net/10150/289173.
Повний текст джерелаDoligalski, Michael Lawrence. "Design and Development of Peptidomimetic Ligands for Targeting Radiopharmaceuticals, Imaging Probes, and Immunotherapeutics in Oncologic Disease." Scholar Commons, 2016. http://scholarcommons.usf.edu/etd/6492.
Повний текст джерелаКниги з теми "Peptidomimetic inhibitors"
Atta-ur-Rahman, ed. Advances in Organic Synthesis: Volume 17. BENTHAM SCIENCE PUBLISHERS, 2022. http://dx.doi.org/10.2174/97898150405241221701.
Повний текст джерелаЧастини книг з теми "Peptidomimetic inhibitors"
Mayo, Kevin H. "From Carbohydrate to Peptidomimetic Inhibitors of Galectins." In ACS Symposium Series, 61–77. Washington, DC: American Chemical Society, 2012. http://dx.doi.org/10.1021/bk-2012-1115.ch003.
Повний текст джерелаRo, Seonggu, Jinho Lee, Seon-Goan Baek, Hae Yeon Cho, Jong Hyun Kim, Dong-Kyu Shin, Won-Hee Jung, et al. "Design of peptidomimetic farnesyltransferase inhibitors as anticancer agents." In Peptides for the New Millennium, 461–62. Dordrecht: Springer Netherlands, 2002. http://dx.doi.org/10.1007/0-306-46881-6_183.
Повний текст джерелаIserloh, Ulrich, and Jared N. Cumming. "Peptidomimetic BACE1 Inhibitors for Treatment of Alzheimer's Disease: Design and Evolution." In Aspartic Acid Proteases as Therapeutic Targets, 441–79. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2011. http://dx.doi.org/10.1002/9783527630943.ch16.
Повний текст джерелаKiso, Yoshiaki, Hikaru Matsumoto, Tomonori Hamawaki, Youhei Sohma, Tooru Kimura, and Yoshio Hayashi. "Prodrug Forms of Peptidomimetic HIV Protease Inhibitors Using Intramolecular Cyclization Reaction." In Peptides: The Wave of the Future, 650–51. Dordrecht: Springer Netherlands, 2001. http://dx.doi.org/10.1007/978-94-010-0464-0_302.
Повний текст джерелаAlmquist, Ronald G., Cris Olsen, Charles K. Hiebert, Srinivasa R. Kadambi, Susan Brandt, and Lawrence R. Toll. "Development of peptidomimetic inhibitors of a newly isolated atrial peptide-degrading enzyme." In Peptides, 791–92. Dordrecht: Springer Netherlands, 1992. http://dx.doi.org/10.1007/978-94-011-2264-1_318.
Повний текст джерелаBursavich, Matthew G., and Daniel H. Rich. "Solution and Solid Phase Synthesis of Non-Peptide Peptidomimetic Aspartic Peptidase Inhibitors." In Peptides: The Wave of the Future, 537–38. Dordrecht: Springer Netherlands, 2001. http://dx.doi.org/10.1007/978-94-010-0464-0_249.
Повний текст джерелаPlummer, M., J. Hamby, E. Lunney, G. Hingorani, C. Humblet, B. Batley, and S. Rapundalo. "Topographically designed peptidomimetic inhibitors of human renin: Incorporation of novel, tethered P1 → P3 side chain functionalization." In Peptides, 634–36. Dordrecht: Springer Netherlands, 1994. http://dx.doi.org/10.1007/978-94-011-0683-2_209.
Повний текст джерелаKamath, Jayesh R., Ruiwu Liu, Amanda M. Enstrom, Gang Liu, and Kit S. Lam. "Development of Peptidomimetic Substrates and Inhibitors that Bind to the Peptide Binding Pocket of the Catalytic Site of p60c-src Protein Tyrosine Kinase." In Peptides: The Wave of the Future, 183–84. Dordrecht: Springer Netherlands, 2001. http://dx.doi.org/10.1007/978-94-010-0464-0_81.
Повний текст джерелаSham, Hing L. "Fluorine-Containing Peptidomimetics as Inhibitors of Aspartyl Proteases." In ACS Symposium Series, 184–95. Washington, DC: American Chemical Society, 1996. http://dx.doi.org/10.1021/bk-1996-0639.ch014.
Повний текст джерелаS Mainkar, Prathama, Surender Singh Jadav, and Kiranmai Nayani. "Peptidomimetics: Current and Future Perspectives on HIV Protease Inhibitors." In Advances in Organic Synthesis, 174–290. BENTHAM SCIENCE PUBLISHERS, 2022. http://dx.doi.org/10.2174/9789815040524122170007.
Повний текст джерелаТези доповідей конференцій з теми "Peptidomimetic inhibitors"
Wang, Xiaoju. "Abstract 189: Development of peptidomimetic inhibitors of theERGgene fusion product in prostate cancer." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-189.
Повний текст джерелаWang, Xiaoju. "Abstract 5535: Development of peptidomimetic inhibitors of the ERG transcription factor in prostate cancer." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-5535.
Повний текст джерелаTymecka, Dagmara, Patrycja Redkiewicz, Piotr F. J. Lipiński, and Aleksandra Misicka. "Search for Peptidomimetic Inhibitors of the VEGF-A165 / NRP-1 Complex with Modification of the C-Terminal Arginine." In 36th European Peptide Symposium. The European Peptide Society, 2022. http://dx.doi.org/10.17952/36eps/36eps.2022.109.
Повний текст джерелаSenapedis, William T., Erkan Baloglu, Doriana Froim, Dilara McCauley, Yuh Min Chook, Michael Kauffman, Sharon Shacham, et al. "Abstract PR1:In silicodesigned covalent peptidomimetic inhibitors (KPT-SINE) of CRM1 modulate tumor suppressor protein nuclear export and induce apoptosis in cancer cells." In Proceedings: AACR Special Conference on Chemical Systems Biology: Assembling and Interrogating Computational Models of the Cancer Cell by Chemical Perturbations--Jun 27-30, 2012; Boston, MA. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.csb12-pr1.
Повний текст джерелаEttouati, Laurent, Marie-Emmanuelle Million, Ophélie Arnaud, Géraldine Agusti, Waël Zeinyeh, Lucia Gonzalez-Lobato, Ali Koubeissi, et al. "Advances in peptidomimetics as inhibitors of ABC transporters." In 1st International Electronic Conference on Medicinal Chemistry. Basel, Switzerland: MDPI, 2015. http://dx.doi.org/10.3390/ecmc-1-a043.
Повний текст джерелаSilva-Júnior, Edeildo, Érica Rodrigues, Hannah Maus, Stefan Hammerschmidt, João Araújo-Júnior, and Tanja Schirmeister. "A new furin-based peptidomimetic as an inhibitor of NSB2-NS3 protease from Zika virus (ZIKV)." In 7th International Electronic Conference on Medicinal Chemistry. Basel, Switzerland: MDPI, 2021. http://dx.doi.org/10.3390/ecmc2021-11431.
Повний текст джерелаAnbalagan, Murali, Mei Sheng, Brian Fleischer, David Hangauer та Brian G. Rowan. "Abstract 3859: Peptidomimetic Src kinase inhibitor KX-01 sensitizes estrogen receptor α-negative breast tumor xenografts to tamoxifen by inducing ERα re-expression". У Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-3859.
Повний текст джерелаChittamuru, Sumathi, Timothy M. Murphy, Sara A. Little, Andrew A. Taylor, Roseanne Wexler, and Laxman Desai. "Abstract P39: Pre-clinical evaluation of NEOS-223, an (S)-valine-thiazole derived peptidomimetic N-heterocycle, as an anticancer agent and P-glycoprotein inhibitor." In Abstracts: AACR Virtual Meeting: COVID-19 and Cancer; February 3-5, 2021. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1557-3265.covid-19-21-p39.
Повний текст джерелаЗвіти організацій з теми "Peptidomimetic inhibitors"
Altstein, Miriam, and Ronald Nachman. Rationally designed insect neuropeptide agonists and antagonists: application for the characterization of the pyrokinin/Pban mechanisms of action in insects. United States Department of Agriculture, October 2006. http://dx.doi.org/10.32747/2006.7587235.bard.
Повний текст джерела